Translating clinical trial efficacy data into population-level impact: a microsimulation model to compare APOC3 RNA inhibition on lowering triglycerides
Journal of Comparative Effectiveness Research · 18.11.2026
DOI: 10.57264/cer-2026-0095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Comparative Effectiveness Research, online erschienen am 18.11.2026. Verfasst von Nihar R Desai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Yale School of Medicine, 333 Cedar St., New Haven, CT 06510, USA. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Aim: Familial chylomicronemia syndrome (FCS) is a rare disorder caused by severe hypertriglyceridemia which increases risk for life-threatening acute pancreatitis (AP). The aim of this study was to indirectly compare the effectiveness of two novel triglyceride (TG)-lowering APOC3 RNA inhibitors in these patients. Materials & methods: An individual patient simulation model was developed and implemented using Monte Carlo sampling to assess the impact of novel FCS treatments, plozasiran versus olezarsen, on serum TG levels. Patient-level heterogeneity was captured through a distribution of pre-treatment TG levels matching the PALISADE trial cohort in the base case. Uncertainty in treatment response (percent reduction of TG levels) was modeled using beta distributions with parameters based on the pivotal PALISADE and BALANCE trials for plozasiran and olezarsen, respectively. The proportion of patients who achieved TG levels of
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yale School of Medicine, 333 Cedar St., New Haven, CT 06510, USA.
- ADVI Health, LLC, 1000 F St. NW, Suite 650, Washington, DC 20004, USA.
ORCID-Profile: Nihar R Desai, Katalin Bognar, Amanda Speller, Ashis K Das
Zitieren
APA
Desai, N. R., Bognar, K., Speller, A., & Das, A. K. (2026). Translating clinical trial efficacy data into population-level impact: a microsimulation model to compare APOC3 RNA inhibition on lowering triglycerides. Journal of Comparative Effectiveness Research. https://doi.org/10.57264/cer-2026-0095
Vancouver
Desai NR, Bognar K, Speller A, Das AK. Translating clinical trial efficacy data into population-level impact: a microsimulation model to compare APOC3 RNA inhibition on lowering triglycerides. Journal of Comparative Effectiveness Research. 2026. doi:10.57264/cer-2026-0095
BibTeX
@article{Desai2026,
author = {Desai, Nihar R and Bognar, Katalin and Speller, Amanda and Das, Ashis K},
title = {Translating clinical trial efficacy data into population-level impact: a microsimulation model to compare APOC3 RNA inhibition on lowering triglycerides},
journal = {Journal of Comparative Effectiveness Research},
year = {2026},
doi = {10.57264/cer-2026-0095}
}
EUVIMED